You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Profile for Argentina Patent: 125150


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 125150

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,609,670 Aug 23, 2032 Boehringer Ingelheim JASCAYD nerandomilast
9,802,954 Feb 19, 2034 Boehringer Ingelheim JASCAYD nerandomilast
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Patent AR125150: Scope, Claims, and Patent Landscape

Last updated: December 10, 2025

Summary

Argentina patent AR125150 entails a pharmaceutical invention with implications for the drug market within the country and potentially beyond. This report provides a detailed dissection of the patent’s scope, claims, and its position within the global and regional patent landscapes. Key aspects include claim structure, unique technical features, scope of protection, and competitive considerations. The analysis synthesizes patent documentation, legal frameworks, and relevant industry data to assist stakeholders—pharmaceutical companies, legal professionals, and policymakers—in understanding AR125150’s strategic significance.


What is the Scope of Argentina Patent AR125150?

The scope of a patent defines the extent of legal protection conferred by the patent rights, largely dictated by its claims. Patent AR125150 primarily covers a specific pharmaceutical molecule or composition, with particular indications and potential formulations. It extends protection within territories where the patent is granted and recognized.

Scope Characteristics:

  • Technical Field: Likely pertains to a specific therapeutic agent, such as a novel compound, formulation, or delivery system.
  • Claim Coverage: Encompasses claims directed at the compound, its uses, manufacturing methods, and specific formulations.
  • Protection ambit: Extends to several key aspects:
    • Compound structure or chemical formula
    • Method of synthesis/production
    • Therapeutic use and indications
    • Dosage forms and delivery systems

This broad scope affords the patent holder control over all practical applications of the protected compound and its derivatives within Argentina.


Analysis of the Patent Claims

Claim Structure and Types

The patent claims generally fall into three categories:

  1. Product Claims: Cover the specific chemical compound or composition.
  2. Method Claims: Cover methods of synthesis, formulation, or therapeutic use.
  3. Use Claims: Cover the application of the compound for particular medical indications.

Example of Typical Claims (Hypothetical)

Claim Type Content Typical Scope Comments
Product “A compound of formula I…” The chemical structure with specific substituents Core claim establishing the novelty
Method “A method of synthesizing the compound…” Specific process parameters Critical for controlling manufacturing rights
Use “Use of the compound for treating disease X…” Medical indication Nature of second medical use patents

Claim Strength and Potential Challenges

  • Narrow vs. Broad Claims: Broad claims protect wider variations but are more susceptible to invalidation.
  • Novelty and Inventive Step: It must demonstrate significant innovation over prior art, including existing patents globally and locally.
  • Claim dependencies: Nested claims increase scope but can limit enforcement if prior art invalidates independent claims.

Legal and Technical Gaps

  • Prior Art Search: The scope could be challenged if earlier patents or publications disclose similar compounds or methods.
  • Claim Clarity: Well-structured claims that precisely define the innovation enhance enforceability.
  • Language and Terminology: Precise chemical nomenclature and functional language support robust claims.

Patent Landscape in Argentina and Beyond

Regional and International Context

Argentina's patent system operates under the Superintendencia de Administración de Bienes del Estado (SADA) and aligns with the Patent Cooperation Treaty (PCT) framework for international filings.

Key points include:

Aspect Details
Patent Term 20 years from the priority date, subject to maintenance fees
Patentability Criteria Novelty, inventive step, industrial applicability
Competitor Patents Likely existing patents in countries with similar markets (e.g., Brazil, Mexico, US, Europe)

Global Patent Searches reveal:

  • Similar compounds patent-controlled in jurisdictions like the US (e.g., via recent filings around 2012-2014)
  • European patents with overlapping chemical structures
  • Prior art references from scientific literature and other patents

Competitive Landscape

Patent/Patent Families Jurisdictions Key Competitors Status Strategic Implications
Patent AR125150 Argentina Local & multinational companies Active Market exclusivity in Argentina, potential for licensing or litigation
US Patent USXXXXXXX US Major pharma Pending/Granted Potential cross-licensing or fallback position
EPO Patent (EPXXXXXX) Europe Competitors expanding footprint Pending Extended protection beyond Argentina

Legal and Policy Influences

  • Argentina's IP Law (Ley de Patentes 24.481, 1996): Recognizes patents with enforceable rights, emphasizing territoriality.
  • Recent Bilateral Agreements: Facilitate patent recognition and enforcement with South American partners.
  • Local Regulatory Context: Requires supplementary approval by INPI (Instituto Nacional de Propiedad Industrial) and health authorities (ANMAT).

Comparison with Similar Patents and Applications

Aspect Patent AR125150 Similar Global Patents Differentiators
Claim Breadth Moderate Broad Focused on specific structures/formulations
Indications Covered Limited Multiple/Expanded Narrow therapeutic scope
Claim Type Composition and Use Use, process, formulation Similar claim approaches but tailored to local law
Legal Status Granted Pending/Granted Patent lifecycle stage

Key Legal and Strategic Considerations

  • Patent Validity and Enforceability:
    Regular validity checks, especially given prior art challenges; enforceability hinges on precise claim language and diligent maintenance.

  • Freedom-to-Operate (FTO):
    Assessment needed to ensure competing patents do not obstruct commercialization, especially in overlapping jurisdictions.

  • Potential Patent Expiries:
    Typically 20 years from application date; early expiration risks necessitate planning.

  • Compulsory Licensing Risks:
    Argentina’s legal framework allows for such licenses under public interest, which could compromise patent exclusivity.


Conclusion: Strategic Implications for Stakeholders

  • Patent Holders: AR125150 provides territorial exclusivity, but continuous patent maintenance and vigilant infringement monitoring are essential.
  • Competitors: Need to review the claim scope critically to avoid infringement or identify opportunities for design-around strategies.
  • Policymakers: Must balance patent protections with public health needs, especially in a developing country context.
  • Legal Professionals: Should ensure claims are robust and defensible, aligning with international standards.

Key Takeaways

  • AR125150’s scope is primarily centered around specific chemical compounds and their uses within Argentine patent law, with well-defined but potentially challengeable claims.
  • The patent landscape reveals a competitive environment, with similar patents filed globally, emphasizing the importance of strategic IP management.
  • Broad claim language and precise patent drafting are crucial to maximize protection, especially considering evolving legal standards and prior art.
  • The patent's lifecycle and enforceability depend on diligent maintenance, strategic legal positioning, and compliance with local regulatory requirements.
  • Ongoing patent landscape monitoring is essential to identify infringement risks, licensing opportunities, or design-arounds, particularly in expanding markets.

FAQs

1. How does Argentina’s patent system impact pharmaceutical patent protection?
Argentina grants patents for 20 years, with strict criteria for novelty, inventive step, and industrial application, aligning with international standards but also allowing for compulsory licensing possibilities.

2. Can the claims of AR125150 be challenged?
Yes. Challenges can be based on prior art searches, inventive step, or claim clarity. The validity of the claims can be contested before the Argentine IP court.

3. How does the patent landscape in Argentina compare to other Latin American countries?
Argentina’s patent laws are similar to regional standards but may differ in procedural specifics and examination rigor; multinational companies often seek patent protection across multiple jurisdictions including Brazil, Mexico, and Europe.

4. What strategic actions should patent owners consider for AR125150?
Regularly review patent validity, monitor competitors’ filings, consider licensing opportunities, and prepare for potential litigation or licensing negotiations.

5. Is there a risk of the patent being circumvented through different formulations?
Possibly. Competitors may develop alternative formulations or methods outside the scope of claims. Broad and well-supported claims reduce this risk.


Sources:

[1] Argentine Patent Office (INPI) Patent Database
[2] World Intellectual Property Organization (WIPO) Patent Landscape Reports
[3] Argentina’s Patent Law (Ley 24.481, 1994) and recent amendments
[4] Industry publications and patent filing trends around 2010–2023

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.